Disc Medicine
NASDAQ: IRON6 known investors
Disc Medicine develops treatments for hematologic diseases, ranging from rare blood disorders to chronic conditions affecting patients worldwide. The company focuses on new approaches in blood-related biology.
BiotechHealthtech
Investors · 6
Competitors · 2
by search overlapBioworld30 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Seeking Alpha26 shared keywordsSeeking Alpha is a financial research platform that provides stock analysis, investment tools, and market coverage across asset classes to investors. The platform aggregates research from thousands of analysts and investors, offering ratings, articles, and investment ideas.
Companies competing with Disc Medicine for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Disc Medicine faces class action after FDA reje... | Pluangpluang.com · Aug 2026Frequently asked questions
- What does Disc Medicine do?
- Disc Medicine develops treatments for hematologic diseases, ranging from rare blood disorders to chronic conditions affecting patients worldwide. The company focuses on new approaches in blood-related biology.
- Who are Disc Medicine's investors?
- Disc Medicine's investors include Access Biotechnology, Atlas Venture, Bain Capital Life Sciences, Foresite Capital, Frazier Life Sciences, OrbiMed.